Tyler Sandow

Interventional radiologists Dr. Juan Gimenez and Dr. Tyler Sandow discuss managing hepatocellular carcinoma (HCC) in this episode. They delve into topics like lobar treatment vs. radiation segmentectomy, ablation and Y-90 combination, preoperative mapping, cone-beam CT, complex cases, treatment plans, and current research pursuits. Important points include new developments in tumor markers and the role of albumin in HCC. They also touch upon combination therapies, collaboration with oncologists, and the use of segmentectomy for metastatic disease.

Dr. Siddarth Padia, Dr. Tyler Sandow, Dr. Kavi Krishnasamy, and Dr. Kevin Burns share their journeys in interventional oncology, exploring how they transitioned from general radiology to specializing in liver cancer. They discuss innovative telehealth solutions and hybrid care models that enhance patient access and communication. The doctors emphasize the importance of clinic support and how integrating advanced technologies can drive procedural growth. Finally, they highlight the role of mentorship and relationship-building in overcoming challenges in establishing successful practices.

Dr. Juan Gimenez and Dr. Tyler Sandow, experienced interventional radiologists, discuss the management of hepatocellular carcinoma (HCC). They cover topics such as building strong relations with transplant surgeons, working-up patients with HCC, effective interventional oncology services, and factors that guide their treatment plan using the Barcelona Clinic Liver Cancer (BCLC) staging algorithm. Stay tuned for Part 2 of this discussion.